OBALON THERAPEUTICS CEO Andrew Rasdal's 2018 pay jumps 98% to $2.3M
OBALON THERAPEUTICS reports 2018 executive compensation
By ExecPay News
Published: June 13, 2019
OBALON THERAPEUTICS reported fiscal year 2018 executive compensation information on June 13, 2019.
In 2018, three executives at OBALON THERAPEUTICS received on average a compensation package of $1.5M, a 35% increase compared to previous year.
Average pay of disclosed executives at OBALON THERAPEUTICS
Andrew Rasdal, Chief Executive Officer, received $2.3M in total, which increased by 98% compared to 2017. 49% of Rasdal's compensation, or $1.1M, was in option awards. Rasdal also received $520K in non-equity incentive plan, $650K in salary, as well as $978 in other compensation.
Kelly Huang, Chief Operating Officer, received a compensation package of $1.1M, which decreased by 33% compared to previous year. 38% of the compensation package, or $432K, was in salary.
William Plovanic, Chief Financial Officer, earned $1.1M in 2018.
Related executives
You may also like
Source: SEC filing on June 13, 2019.